Steven Cohen's HCAT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 19,929 shares of Health Catalyst, Inc. (HCAT) worth $34,477, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in HCAT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 1.49 M shares. Largest reduction occurred in Q1 2024, reducing 2.12 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Health Catalyst (HCAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Health Catalyst (HCAT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +19,929 | New Buy | 19,929 | $1.73 |
| Q1 2025 | -215,160 | Sold Out | 0 | $0.00 |
| Q4 2024 | -301,774 | Reduce 58.38% | 215,160 | $7.07 |
| Q3 2024 | +211,805 | Add 69.41% | 516,934 | $8.14 |
| Q2 2024 | -1.73 M | Reduce 84.99% | 305,129 | $6.39 |
| Q1 2024 | -2.12 M | Reduce 51.09% | 2.03 M | $7.53 |
| Q4 2023 | +273,514 | Add 7.04% | 4.16 M | $9.26 |
| Q3 2023 | +1.49 M | Add 62.01% | 3.88 M | $10.12 |
| Q2 2023 | +1.01 M | Add 72.85% | 2.4 M | $12.50 |
| Q1 2023 | -179,100 | Reduce 11.44% | 1.39 M | $11.67 |
| Q4 2022 | -362,400 | Reduce 18.79% | 1.57 M | $10.63 |
| Q3 2022 | +948,234 | Add 96.74% | 1.93 M | $9.70 |
| Q2 2022 | +767,231 | Add 360.31% | 980,166 | $14.49 |
| Q1 2022 | +212,935 | New Buy | 212,935 | $26.13 |
| Q4 2021 | -202,194 | Sold Out | 0 | $0.00 |
| Q3 2021 | +6,008 | Add 3.06% | 202,194 | $50.01 |
| Q2 2021 | +196,186 | New Buy | 196,186 | $55.51 |
| Q1 2021 | -322,388 | Sold Out | 0 | $0.00 |
| Q4 2020 | -490,591 | Reduce 60.34% | 322,388 | $43.53 |
| Q3 2020 | -265,103 | Reduce 24.59% | 812,979 | $36.60 |
| Q2 2020 | +279,616 | Add 35.02% | 1.08 M | $29.17 |
| Q1 2020 | +798,466 | New Buy | 798,466 | $26.15 |
Steven Cohen's Health Catalyst Investment FAQs
Steven Cohen first purchased Health Catalyst, Inc. (HCAT) in Q1 2020, acquiring 798,466 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Health Catalyst, Inc. (HCAT) for 22 quarters since Q1 2020.
Steven Cohen's largest addition to Health Catalyst, Inc. (HCAT) was in Q3 2023, adding 3,883,852 shares worth $39.3 M.
According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 19,929 shares of Health Catalyst, Inc. (HCAT), valued at approximately $34,477.
As of the Q3 2026 filing, Health Catalyst, Inc. (HCAT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Health Catalyst, Inc. (HCAT) was 4,157,366 shares, as reported at the end of Q4 2023.